Cellnovo

CLNV

FR0012633360

Software

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-.--%	-.--%

2019	Cellnovo Group Stops Manufacturing and Commercial Operations	CI
2019	Cellnovo Group Sa Provides Revenue Guidance for the First Quarter of 2019	CI

Cellnovo Group Reports Sales Results for the Fourth Quarter and Year Ended December 31, 2016

January 31, 2017 at 11:45 am

Cellnovo Group reported sales results for the fourth quarter and year ended December 31, 2016. For the quarter, sales were EUR 363,153 against EUR 346,194 a year ago. For the year, sales were EUR 1,416,744 against EUR 608,125 a year ago.

Latest news about Cellnovo

Cellnovo Group Stops Manufacturing and Commercial Operations	19-03-28	CI
Cellnovo Group Sa Provides Revenue Guidance for the First Quarter of 2019	19-03-21	CI
Cellnovo Group SA Announces Expands its Base of Potential Users	19-02-18	CI
Cellnovo Group Launches New Mobile Application Connected to Continuous Glucose Monitoring Data Via HealthKit	19-02-06	CI
Cellnovo Group SA announced that it has received €1.5 million in funding from Yorkville Advisors Global LP	19-01-28	CI
Cellnovo Group Announces Sales Results for the Fourth Quarter and Full Year of 2018	19-01-15	CI
Cellnovo Group Announces the Drawing of Second Tranche of Financing of €3 Million from Kreos Capital	19-01-14	CI
Cellnovo Group SA announced that it expects to receive €1.5 million in funding from Yorkville Advisors Global LP	19-01-13	CI
Cellnovo and ForaCare Signs an Agreement to Connect ForaCare’s Glucose Monitoring Device to the Cellnovo Gen 3 System	18-12-03	CI
Cellnovo Group SA Signs New Collaboration to Allow for Automatic Data Transfer from Roche’s Accu-Chek Bluetooth-Enabled Blood Glucose Meters to the Cellnovo Gen 3 System	18-11-28	CI
Cellnovo Group Announces Distribution Agreement in Colombia with Diabetrics	18-10-29	CI
Cellnovo Group Announces Sales Results for the Third Quarter and Nine Months Ended September 30, 2018	18-10-11	CI
Cellnovo Group Announces Launch of its Gen 3 System	18-09-05	CI
Cellnovo Group Announces Sales Results for the Second Quarter and Earnings Results for the Half Year Ended June 30, 2018	18-07-26	CI
Cellnovo Group SA announced that it expects to receive €3 million in funding from Kreos Capital	18-07-25	CI
Cellnovo Limited Elects Pierre Chancel as A Board Member	18-05-29	CI
Cellnovo Group Reports Earnings Results for the Year Ended December 31, 2017; Reports Sales Results for the First Quarter Ended March 31, 2018	18-04-11	CI
Cellnovo Group Updates on Results of Cellnovo’s Diabetes Management System	18-02-14	CI
Cellnovo Group Announces Sales Results for the Fourth Quarter and Full Year Ended December 31, 2017	18-01-17	CI
Cellnovo Group Announces the Launch of the First Clinical Study in the EU-Funded PEPPER Project	17-12-14	CI
Cellnovo Announces the CE Marking of the First Bluetooth and Android-Enabled Micro-Pump for Insulin Delivery	17-12-13	CI
Cellnovo Provides an Update on Its Partnership with Diabeloop for the Development of an Artificial Pancreas Solution	17-11-03	CI
Cellnovo Group Announces Sales Results for the Third Quarter and Nine Months Ended September 30, 2017	17-10-25	CI
Cellnovo Group Announces Earnings Results for the Half Year Ended June 30, 2017	17-09-25	CI
Cellnovo Group Provides Update on 510(K) Submission for Clearance of the Cellnovo Diabetes Management System	17-09-08	CI

Chart Cellnovo

Duration

Period

More charts

Company Profile

Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.

Sector

Software

More about the company

Sector Mobile Application Software

	1st Jan change	Capi.
CELLNOVO	-.--%	2.68M
SNAP INC.	-4.25%	26.71B
LIFE360, INC.	+121.03%	2.56B
BEIJING ULTRAPOWER SOFTWARE CO., LTD.	-8.93%	2.18B
ZHEJIANG JINKE TOM CULTURE INDUSTRY CO., LTD.	-28.95%	1.7B
FINVOLUTION GROUP	+1.43%	1.29B
HELLO GROUP INC.	-4.89%	1.22B
KAKAO GAMES CORP.	-24.72%	1.15B
DENA CO., LTD.	+17.10%	1.14B
SHANGHAI YAOJI TECHNOLOGY CO., LTD.	-20.03%	1.01B

Mobile Application Software

Cellnovo

Equities

CLNV

FR0012633360

Software

Cellnovo Group Reports Sales Results for the Fourth Quarter and Year Ended December 31, 2016

Latest news about Cellnovo

Chart Cellnovo

Company Profile

Sector Mobile Application Software